COMMUNIQUÉS West-GlobeNewswire

Progressive Care Inc. Announces Month-End Sales Figures Showing Increase in Year-Over-Year Prescriptions Filled in June 2018
17/07/2018
MIAMI, July 17, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a personalized healthcare services and technology company, today announced further growth year-over-year in both revenue and number of [...]
electroCore and UpScript Launch Program to Offer Direct-to-Patient Telemedicine Option for gammaCore™ in the United States
17/07/2018
BASKING RIDGE, N.J., July 17, 2018 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq:ECOR), a commercial-stage bioelectronic medicine company, announced today a program with UpScript, a digital healthcare platform, offering [...]
Cellectar Reports 94% Reduction in Overall Tumor Volume in Waldenstrom Macroglobulinemia Patient in Phase 2 CLR 131 Clinical Study
17/07/2018
MADISON, Wis., July 17, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq:CLRB), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of [...]
Avadel Pharmaceuticals to Report Second Quarter 2018 Results
17/07/2018
DUBLIN, Ireland, July 17, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq:AVDL), today announced it will report its second quarter 2018 financial results on Tuesday, August 7, 2018, before the market open. A [...]
Parkinson’s Disease Pathogenesis may have a Bacterial Virus Component According to Research Conducted by Human Microbiology Institute
17/07/2018
Full study data published in Scientific Reports NEW YORK, July 17, 2018 (GLOBE NEWSWIRE) -- Human Microbiology Institute (HMI), a not-for-profit scientific research organization, and Tetz Laboratories today announced [...]
Innovation Pharmaceuticals Signs Drug Product Manufacturing Contract with CoreRx to Formulate and Package Brilacidin for Oral Mucositis in Sachet Form
17/07/2018
BEVERLY, Mass., July 17, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to report the Company has signed a Drug Product [...]
Eloxx Pharmaceuticals To Report Second Quarter 2018 Financial Results On August 7, 2018 and Host Webcast and Conference Call
17/07/2018
WALTHAM, Mass., July 17, 2018 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic [...]
VitalHub Announces First Municipal Client Sale for VH LTC Solution
17/07/2018
TORONTO, July 17, 2018 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV:VHI) is pleased to announce the sale of VH LTC solution to the Seniors’ Services division of the Region of Waterloo, marking [...]
The Lefebvre Foundation: Man taking seven million steps for cancer will walk from North Bay to Quebec in coming weeks
17/07/2018
NORTH BAY, Ontario, July 17, 2018 (GLOBE NEWSWIRE) -- When Jimmy Lefebvre lost his father to cancer he couldn’t accept how his father was forced to quickly succumb to the disease. Lefebvre is now over half-way across [...]
Voyager Therapeutics Receives FDA Guidance on Development Path for VY-AADC for Parkinson’s Disease and Provides Clinical Update
17/07/2018
Voyager continues to plan to submit a BLA for VY-AADC based on its pivotal program and Type C meeting feedback Positive interim results with VY-AADC from the Phase 1 posterior trajectory trial supports the surgical [...]
Asterias Provides Six Month Data Readout for its AST-OPC1 Phase 1/2a Clinical Trial in Severe Spinal Cord Injury
17/07/2018
- Current Readout Includes New Six Month Data for Cohort 5 and Aggregate Trial Data - - Results Continue to Demonstrate Favorable Safety Profile, Potential for Durable Cell Engraftment at the Injury Site and Improved [...]
Evogene and IMAmt Enter a Collaboration in the Field of Insect Resistance Traits in Cotton
17/07/2018
Evogene will identify candidate toxins mainly against Cotton Boll Weevil and IMAmt will validate the toxins REHOVOT, Israel and CUIABÁ/MT, Brazil, July 17, 2018 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ:EVGN) (TASE:EVGN [...]
Resverlogix Announces Upcoming Presentations at Clinical Trials in Alzheimer’s Disease (CTAD) Asia and Alzheimer’s Association International Conference (AAIC)
17/07/2018
CALGARY, Alberta, July 17, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX:RVX) announced today that it has been awarded two presentations at the Clinical Trials in Alzheimer’s Disease ( [...]
BioTelemetry, Inc. to Release Second Quarter 2018 Earnings Results on July 25, 2018
17/07/2018
MALVERN, Pa., July 17, 2018 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its second quarter 2018 earnings on Wednesday, July 25 at 4:00 PM Eastern Time. The BioTelemetry quarterly conference call [...]
Axsome Therapeutics Announces AXS-05 Presentation at the 2018 Alzheimer’s Association International Conference
17/07/2018
NEW YORK, July 17, 2018 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, [...]
Capricor and USAISR Announce Collaboration to Investigate Exosome Platform to Treat Injured Troops
17/07/2018
Research to Explore Potential for CAP-2003 to Address Trauma-related Injuries LOS ANGELES, July 17, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ:CAPR) today announced it has entered into an agreement with the [...]
Auxly Congratulates Streaming Partner CannTx Life Sciences on Obtaining Cultivation Licence
17/07/2018
VANCOUVER, British Columbia, July 17, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V:XLY) (" Auxly " or the " Company ") is pleased to announce that Auxly’s streaming partner, CannTx Life Sciences Inc. (“ [...]
APEIRON Appoints Peter Llewellyn-Davies as Chief Executive Officer
17/07/2018
The Former CEO, Dr. Hans Loibner, Will Continue to Support the Company as Senior Advisor VIENNA, Austria, July 17, 2018 (GLOBE NEWSWIRE) -- APEIRON Biologics AG, a company focused on cancer immunotherapy, today [...]
PotNetwork Holdings, Inc., With Sales of Over $10 Million Year-To-Date, Moves Toward Uplisting and Expansion
17/07/2018
FT. LAUDERDALE, Fla., July 17, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--PotNetwork Holdings, Inc. (OTC Pink:POTN) on July 13 th , the Company announced that it had filed a Form 10 registration statement with the [...]

Pages